Uses of Gamma Irradiated Amniotic Membrane as an Alternative Method in Psoriasis Treatment

Egyptian Atomic Energy Authority

Status: Completed

Conditions: Psoriasis

Treatments: Combination Product: REGE pro

Study type: Interventional

Funder types: Other

Identifiers

NCT03440541

4102017NCRRT

Details and patient eligibility

About

Using of human amniotic membrane extra-cellular matrix as a topical treatment for improving Psoriasis Area and Severity Index (PASI).

Full description

Human amniotic membrane extra-cellular matrix was purchased from National center for radiation research and technology, Egypt, under commercial name REGE pro gel.

Enrollment: 22 patients

Sex: All

Ages: 20 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• patients have psoriasis lesion

Exclusion criteria

• must stop other line of treatment

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

22 participants in 1 patient group

treated

Experimental group

Description:

Patients who received patches of REGE pro on psoriasis lesion weekly for 8 weeks

Treatment:

Combination Product: REGE pro